Frontiers in Pharmacology (Sep 2016)

Systematic Review and Meta-Analysis of the Efficacy and Safety of Telavancin for Treatment of Infectious Disease: Are We Clearer?

  • Junlan Chuan,
  • Yuan Zhang,
  • Xia He,
  • Yuxuan Zhu,
  • Lei Zhong,
  • Dongke Yu,
  • Hongtao Xiao

DOI
https://doi.org/10.3389/fphar.2016.00330
Journal volume & issue
Vol. 7

Abstract

Read online

Telavancin is approved to treat complicated skin and skin structure infections, hospital-acquired and ventilator-associated bacterial pneumonia caused by Staphylococcus aureus. A previous meta-analysis of randomised controlled trials suggested that it might be an alternative to vancomycin in cases of difficult-to-treat meticillin-resistant Staphylococcus aureus infections. We did a meta-analysis including new trials to access the efficacy and safety of telavancin.

Keywords